Ftse Mib
37.898,78
-0,02%
DAX
22.470,53
-0,62%
S&P 500
6.115,88
0,01%
NASDAQ
19.955,70
0,05%
Bitcoin
96.743,77
0,13%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ EQRx Inc (EQRX) EQRx Inc (EQRX) Notizie

EQRX

EQRx (EQRX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:EQRX
DataOraFonteTitoloSimboloCompagnia
20/11/202322:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:EQRXEQRx Inc
20/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EQRXEQRx Inc
09/11/202322:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQRXEQRx Inc
09/11/202322:05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:EQRXEQRx Inc
09/11/202322:03Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EQRXEQRx Inc
09/11/202315:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQRXEQRx Inc
08/11/202317:30GlobeNewswire Inc.Revolution Medicines and EQRx Stockholders Approve EQRx AcquisitionNASDAQ:EQRXEQRx Inc
06/11/202322:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQRXEQRx Inc
01/11/202313:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:EQRXEQRx Inc
01/11/202312:59Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
01/08/202313:00GlobeNewswire Inc.Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional CapitalNASDAQ:EQRXEQRx Inc
08/05/202323:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EQRXEQRx Inc
08/05/202322:01GlobeNewswire Inc.EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial ResultsNASDAQ:EQRXEQRx Inc
27/04/202314:00GlobeNewswire Inc.EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023NASDAQ:EQRXEQRx Inc
13/03/202314:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EQRXEQRx Inc
23/02/202323:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:EQRXEQRx Inc
23/02/202322:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EQRXEQRx Inc
23/02/202313:00GlobeNewswire Inc.EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate ProgressNASDAQ:EQRXEQRx Inc
22/02/202322:09Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:EQRXEQRx Inc
09/02/202317:29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EQRXEQRx Inc
03/01/202314:00GlobeNewswire Inc.EQRx to Present at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:EQRXEQRx Inc
19/12/202214:00GlobeNewswire Inc.EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung CancerNASDAQ:EQRXEQRx Inc
02/12/202214:00GlobeNewswire Inc.EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung CancerNASDAQ:EQRXEQRx Inc
25/11/202222:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EQRXEQRx Inc
10/11/202213:00GlobeNewswire Inc.EQRx Provides Portfolio and U.S. Commercial Strategy Updates; Reports Third Quarter 2022 Financial ResultsNASDAQ:EQRXEQRx Inc
07/11/202214:00GlobeNewswire Inc.EQRx to Participate in the Jefferies 2022 London Healthcare ConferenceNASDAQ:EQRXEQRx Inc
28/10/202214:00GlobeNewswire Inc.EQRx to Hold Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022NASDAQ:EQRXEQRx Inc
12/08/202222:10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EQRXEQRx Inc
12/08/202222:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EQRXEQRx Inc
11/08/202213:00GlobeNewswire Inc.EQRx Reports Second Quarter 2022 Financial Results and Recent Corporate ProgressNASDAQ:EQRXEQRx Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:EQRX

La tua Cronologia

TG
NADA
Lyxor Asset Management L...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci